Nash, P., Mease, P., Fleishaker, D., Wu, J., Coates, L., Behrens, F., . . . Kanik, K. (2020). Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: A randomised, placebo-controlled substudy of OPAL Balance. Elsevier.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)Nash, P., et al. Tofacitinib as Monotherapy Following Methotrexate Withdrawal in Patients with Psoriatic Arthritis Previously Treated with Open-label Tofacitinib Plus Methotrexate: A Randomised, Placebo-controlled Substudy of OPAL Balance. Elsevier, 2020.
توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)Nash, P., et al. Tofacitinib as Monotherapy Following Methotrexate Withdrawal in Patients with Psoriatic Arthritis Previously Treated with Open-label Tofacitinib Plus Methotrexate: A Randomised, Placebo-controlled Substudy of OPAL Balance. Elsevier, 2020.